An extraordinary general meeting of Gentian Diagnostics AS, reg. no 983 860 516 (the "Company"), will be held..
GENTIAN DIAGNOSTICS AS HAS OBTAINED PROOF OF CONCEPT FOR A NEW PRODUCT FOR EXOCRINE PANCREATIC INSUFICIENCY..
Gentian Diagnostics AS: Directed share issue towards Vatne Equity and Norron
Bård Sundrehagen, Chief Executive Officer in Gentian Diagnostics AS, has today sold 50,000 Shares in Gentian..
(Oslo, 15 June 2018) Reference is made to the stock exchange notice published by Gentian Diagnostics AS..
Safrino AS, a company controlled by Bendik Sundrehagen who is member of the Board of Directors, has today..
The Annual General Meeting of Gentian Diagnostics AS was held 5 June 2018. All proposed resolutions on the..
The 2018 annual general meeting of Gentian Diagnostics AS will be held on 5 June 2018 at 10:00 (CET) at..
The Board of Gentian Diagnostics AS has approved the Annual Report for 2017. The Annual Report is without..